cell and gene therapies

News

Bayer adds US life sciences incubator in Cambridge

Bayer has formally opened a new life sciences incubator in Cambridge, Massachusetts, that will focus on cell and gene therapies (CGT).

Market Access

Navigating Routes to Commercial Excellence in Cell and Gene ...

'Navigating Routes to Commercial Success in Cell and Gene Therapy', authored by Franjo Hanzl, VP, Business Development, Commercial at EVERSANA, Dr.

R&D

CSL reflects on its future, past as new R&D lab opens

Last month, global pharmaceutical maker CSL cut the ribbon on a brand-new research facility in Waltham, Massachusetts, wher

R&D

Allogeneic therapies: The future of cancer treatment?

As autologous cancer therapies have advanced and shown incredible efficacy, the industry is looking for the next step for this type of treatment.

JP Morgan

JPM2023: Breakthroughs await, but so do roadblocks

Editor-in-chief Jonah Comstock lays out a few of the most potent threads he heard in the conference centres, hotel rooms, and rain-soaked Lyfts of San Francisco.

Digital

Key themes from JP Morgan, with Paul Tunnah – the pharmaphor...

This week, pharmaphorum editor-in-chief Jonah Comstock and pharmaphorum founder Paul Tunnah headed to San Francisco for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bi